Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Mr. Michael F. MahoneyChairman, President & CEO | -386,76k | 0,00 | Other Disposition | - | 1,40M | -21,60% |
| 2026-05-20 | Mr. Edward J. LudwigLead Independent Director | 3,58k | 202,91k | Achat | 56,68 | 25,36k | 16,44% |
| 2026-05-20 | Dr. Cheryl B. PegusIndependent Director | 1,77k | 99,99k | Achat | 56,49 | 1,77k | - |
| 2026-05-19 | Mr. David Cyril HabigerIndependent Director | 4,45k | 251,10k | Achat | 55,92 - 56,95 | 13,88k | 47,20% |
| 2026-05-02 | Padraig Andrew O'ConnorInitié | -872,00 | 49,27k | Derivative Exercise and Sale | 56,50 | 7,02k | - |
| 2026-05-02 | Padraig Andrew O'ConnorInitié | 930,00 | 0,00 | Derivative Exercise and Retained Stock | - | 7,02k | 15,26% |
| 2026-05-02 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | -1,01k | 56,90k | Derivative Exercise and Sale | 56,50 | 77,12k | - |
| 2026-05-02 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | 1,10k | 0,00 | Derivative Exercise and Retained Stock | - | 77,12k | 1,44% |
| 2026-03-01 | Ms. Emily M. WoodworthSenior VP, Global Controller & CAO | 466,00 | 0,00 | Derivative Exercise and Retained Stock | - | 2,86k | 19,47% |
| 2026-03-01 | Ms. Emily M. WoodworthSenior VP, Global Controller & CAO | -372,00 | 28,59k | Derivative Exercise and Sale | 76,85 | 2,86k | - |
| 2026-02-19 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | 6,85k | 519,03k | Acquisition Under Employee Benefit Plan | 75,76 | 76,00k | 9,91% |
| 2026-02-14 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | 8,32k | 0,00 | Derivative Exercise and Retained Stock | - | 219,14k | 3,95% |
| 2026-02-13 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -2,80k | 209,02k | Derivative Exercise and Sale | 74,73 | 219,14k | - |
| 2026-02-13 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -34,10k | 2,55M | Sale to Issuer | 74,73 | 219,14k | -13,47% |
| 2026-02-14 | Mr. Michael F. MahoneyChairman, President & CEO | 32,79k | 0,00 | Derivative Exercise and Retained Stock | - | 1,79M | 1,87% |
| 2026-02-13 | Mr. Michael F. MahoneyChairman, President & CEO | -8,83k | 660,02k | Derivative Exercise and Sale | 74,73 | 1,79M | - |
| 2026-02-13 | Mr. Michael F. MahoneyChairman, President & CEO | -139,12k | 10,40M | Sale to Issuer | 74,73 | 1,79M | -7,21% |
| 2026-02-13 | Mr. Jonathan R. MonsonExec. VP & CFO | 2,12k | 0,00 | Derivative Exercise and Retained Stock | - | 37,99k | 5,90% |
| 2026-02-13 | Mr. Jonathan R. MonsonExec. VP & CFO | -1,70k | 126,89k | Derivative Exercise and Sale | 74,73 | 37,99k | - |
| 2026-02-13 | Miriam O'sullivanInitié | 1,88k | 0,00 | Derivative Exercise and Retained Stock | - | 19,03k | 10,97% |
| 2026-02-13 | Miriam O'sullivanInitié | -820,00 | 61,28k | Derivative Exercise and Sale | 74,73 | 19,03k | - |
| 2026-02-13 | Padraig Andrew O'ConnorInitié | 1,61k | 0,00 | Derivative Exercise and Retained Stock | - | 6,09k | 35,84% |
| 2026-02-13 | Padraig Andrew O'ConnorInitié | -987,00 | 73,76k | Derivative Exercise and Sale | 74,73 | 6,09k | - |
| 2026-02-13 | Ms. Emily M. WoodworthSenior VP, Global Controller & CAO | 1,44k | 0,00 | Derivative Exercise and Retained Stock | - | 2,39k | 151,63% |
| 2026-02-13 | Ms. Emily M. WoodworthSenior VP, Global Controller & CAO | -1,27k | 94,83k | Derivative Exercise and Sale | 74,73 | 2,39k | - |
| 2026-02-14 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | 3,69k | 0,00 | Derivative Exercise and Retained Stock | - | 54,24k | 7,30% |
| 2026-02-13 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | -1,12k | 83,55k | Derivative Exercise and Sale | 74,73 | 54,24k | - |
| 2026-02-13 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | -13,46k | 1,01M | Sale to Issuer | 74,73 | 54,24k | -19,88% |
| 2026-02-14 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | 5,72k | 0,00 | Derivative Exercise and Retained Stock | - | 69,15k | 9,02% |
| 2026-02-13 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | -2,24k | 167,17k | Derivative Exercise and Sale | 74,73 | 69,15k | - |
| 2026-02-13 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | -25,68k | 1,92M | Sale to Issuer | 74,73 | 69,15k | -27,08% |
| 2026-02-12 | Miriam O'sullivanInitié | 623,00 | 0,00 | Derivative Exercise and Retained Stock | - | 17,15k | 3,77% |
| 2026-02-12 | Miriam O'sullivanInitié | -338,00 | 25,05k | Derivative Exercise and Sale | 74,12 | 17,15k | - |
| 2026-02-12 | Padraig Andrew O'ConnorInitié | 601,00 | 0,00 | Derivative Exercise and Retained Stock | - | 4,49k | 15,47% |
| 2026-02-12 | Padraig Andrew O'ConnorInitié | -457,00 | 33,87k | Derivative Exercise and Sale | 74,12 | 4,49k | - |
| 2026-02-12 | Ms. Emily M. WoodworthSenior VP, Global Controller & CAO | 239,00 | 0,00 | Derivative Exercise and Retained Stock | - | 951,00 | 33,57% |
| 2026-02-12 | Ms. Emily M. WoodworthSenior VP, Global Controller & CAO | -242,00 | 17,94k | Derivative Exercise and Sale | 74,12 | 951,00 | - |
| 2026-02-12 | Mr. Jonathan R. MonsonExec. VP & CFO | 581,00 | 0,00 | Derivative Exercise and Retained Stock | - | 35,87k | 1,65% |
| 2026-02-12 | Mr. Jonathan R. MonsonExec. VP & CFO | -573,00 | 42,47k | Derivative Exercise and Sale | 74,12 | 35,87k | - |
| 2026-02-12 | Mr. Michael F. MahoneyChairman, President & CEO | 7,08k | 0,00 | Derivative Exercise and Retained Stock | - | 1,63M | 0,44% |
| 2026-02-12 | Mr. Michael F. MahoneyChairman, President & CEO | -6,63k | 491,12k | Derivative Exercise and Sale | 74,12 | 1,63M | - |
| 2026-02-12 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | 1,85k | 0,00 | Derivative Exercise and Retained Stock | - | 175,13k | 1,07% |
| 2026-02-12 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -1,61k | 119,48k | Derivative Exercise and Sale | 74,12 | 175,13k | - |
| 2026-02-12 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | 954,00 | 0,00 | Derivative Exercise and Retained Stock | - | 34,41k | 2,85% |
| 2026-02-12 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | -488,00 | 36,17k | Derivative Exercise and Sale | 74,12 | 34,41k | - |
| 2026-02-12 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | 1,39k | 0,00 | Derivative Exercise and Retained Stock | - | 38,34k | 3,76% |
| 2026-02-12 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | -1,30k | 96,50k | Derivative Exercise and Sale | 74,12 | 38,34k | - |
| 2026-02-02 | Mr. Michael F. MahoneyChairman, President & CEO | -95,75k | 6,48M | Derivative Exercise and Sale | 24,55 - 94,06 | 1,63M | - |
| 2026-02-02 | Mr. Michael F. MahoneyChairman, President & CEO | -65,15k | 6,09M | Automatic Disposition | 93,49 | 1,63M | -3,85% |
| 2025-12-01 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | -17,31k | 1,33M | Derivative Exercise and Sale | 17,26 - 101,55 | 36,95k | - |
| 2025-11-28 | Miriam O'sullivanInitié | -260,00 | 0,00 | Other Disposition | - | 16,53k | -1,55% |
| 2025-11-12 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -10,30k | 0,00 | Other Disposition | - | 173,28k | -5,61% |
| 2025-11-06 | Ms. Ellen M. ZaneIndependent Director | -12,89k | 1,27M | Automatic Disposition | 98,28 | 24,13k | -34,82% |
| 2025-11-03 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -50,00k | 3,67M | Derivative Exercise and Sale | 26,15 - 100,75 | 183,58k | - |
| 2025-10-30 | Mr. Michael F. MahoneyChairman, President & CEO | -149,99k | 0,00 | Other Disposition | - | 1,69M | -8,15% |
| 2025-10-27 | Ms. Ellen M. ZaneIndependent Director | -12,89k | 1,31M | Automatic Disposition | 101,13 - 102,24 | 24,13k | -34,82% |
| 2025-10-01 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -50,00k | 3,62M | Derivative Exercise and Sale | 26,15 - 98,91 | 183,58k | - |
| 2025-09-02 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -50,00k | 3,96M | Derivative Exercise and Sale | 26,15 - 105,85 | 183,58k | - |
| 2025-08-01 | Mr. Edward J. LudwigLead Independent Director | -500,00 | 0,00 | Other Disposition | - | 17,98k | -2,71% |
| 2025-08-01 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -50,00k | 3,92M | Derivative Exercise and Sale | 26,15 - 104,63 | 183,58k | - |
| 2025-08-02 | Mr. Jonathan R. MonsonExec. VP & CFO | 562,00 | 0,00 | Derivative Exercise and Retained Stock | - | 35,29k | 1,62% |
| 2025-08-02 | Mr. Jonathan R. MonsonExec. VP & CFO | -528,00 | 55,66k | Derivative Exercise and Sale | 105,41 | 35,29k | - |
| 2025-08-01 | Mr. Arthur Crosswell ButcherExec. VP and Group President of MedSurg & Asia Pacific | -17,31k | 1,38M | Derivative Exercise and Sale | 17,26 - 104,63 | 36,96k | - |
| 2025-07-29 | Mr. Yoshiaki FujimoriInitié | -2,90k | 310,38k | Vente | 106,99 | 2,08k | -58,23% |
| 2025-07-25 | Mr. Edward J. LudwigLead Independent Director | -4,00k | 424,12k | Vente | 106,03 | 18,48k | -17,79% |
| 2025-07-01 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | 2,08k | 0,00 | Derivative Exercise and Retained Stock | - | 33,45k | 6,64% |
| 2025-07-01 | Mr. Vance R. BrownEVP, General Counsel & Corporate Secretary | -1,95k | 204,53k | Derivative Exercise and Sale | 104,78 | 33,45k | - |
| 2025-07-01 | Mr. Joseph M. FitzgeraldExec. VP & Group President of Cardiovascular | -50,00k | 4,04M | Derivative Exercise and Sale | 26,15 - 106,97 | 183,58k | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
